Antitumor and immunomodulatory activities of thiosemicarbazones and 1,3-Thiazoles in Jurkat and HT-29 cells

详细信息    查看全文

• 作者：Thiago André ; R. dos Santos^a ; ^{thiago.andre.ufpe@gmail.com" class="auth_mail" title="E-mail the corresponding author} ; Aline Caroline da Silva^a ; ^{acllb2003@yahoo.com.br" class="auth_mail" title="E-mail the corresponding author} ; Elany Barbosa Silva^b ; Paulo André ; Teixeira de Moraes Gomes^b ; José ; Wanderlan Pontes Espí ; ndola^b ; Marcos Verí ; ssimo de Oliveira Cardoso^b ; Diogo Rodrigo Magalhaes Moreira^c ; Ana Cristina Lima Leite^b ; ; Valé ; ria R.A. Pereira^a ; ^{valeria@cpqam.fiocruz.br" class="auth_mail" title="E-mail the corresponding author}
• 关键词：Drug development ; Cancer ; Immune system ; 1 ; 3-thiazoles ; Thiosemicarbazones ; Cell death
• 刊名：Biomedicine & Pharmacotherapy
• 出版年：2016
• 出版时间：August 2016
• 年：2016
• 卷：82
• 期：Complete
• 页码：555-560
• 全文大小：752 K

文摘

Cancer remains a high incidence and mortality disease, causing around 8.2 million of deaths in the last year. Current chemotherapy needs to be expanded, making research for new drugs a necessary task. Immune system modulation is an emerging concept in cancer cell proliferation control. In fact, there are a number of mechanisms underlying the role immune system plays in tumor cells. In this work, we describe the structural design, synthesis, antitumor and immunomodulatory potential of 31 new 1,3-thiazole and thiosemicarbazone compounds. Cisplatin was used as anticancer drug control. Cytotoxicity against J774A.1 macrophages and antitumor activity against HT-29 and Jurkat cells was determined. These 1,3-thiazole and thiosemicarbazone compounds not only exhibited cytotoxicity in cancer cells, but were able to cause irreversible cancer cell damage by inducing necrosis and apoptosis. In addition, these compounds, especially pyridyl-thiazoles compounds, regulated immune factors such as interleukin 10 and tumor necrosis factor, possible by directing immune system in favor of modulating cancer cell proliferation. By examining their pharmacological activity, we were able to identify new potent and selective anticancer compounds.